![Solid-phase synthetic strategy and bioevaluation of a labeled delta-opioid receptor ligand Dmt-Tic-Lys for in vivo imaging. - Abstract - Europe PMC Solid-phase synthetic strategy and bioevaluation of a labeled delta-opioid receptor ligand Dmt-Tic-Lys for in vivo imaging. - Abstract - Europe PMC](https://europepmc.org/articles/PMC2756606/bin/nihms-118247-f0006.jpg)
Solid-phase synthetic strategy and bioevaluation of a labeled delta-opioid receptor ligand Dmt-Tic-Lys for in vivo imaging. - Abstract - Europe PMC
![Reagents and conditions: a) 20% piperidine, DMF. b) Fmoc-Lys[Mtt]-OH,... | Download Scientific Diagram Reagents and conditions: a) 20% piperidine, DMF. b) Fmoc-Lys[Mtt]-OH,... | Download Scientific Diagram](https://www.researchgate.net/profile/Mohanad-Mossalam/publication/235364289/figure/fig1/AS:214257531658240@1428094384605/Reagents-and-conditions-a-20-piperidine-DMF-b-Fmoc-LysMtt-OH-HBTU-HOBt-DIPEA_Q320.jpg)
Reagents and conditions: a) 20% piperidine, DMF. b) Fmoc-Lys[Mtt]-OH,... | Download Scientific Diagram
![167393-62-6 | Fmoc-Lys(Mtt)-OH | N2-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N6-[(4-methylphenyl)diphenylmethyl]-L- lysine | C₄₁H₄₀N₂O₄ | TRC 167393-62-6 | Fmoc-Lys(Mtt)-OH | N2-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N6-[(4-methylphenyl)diphenylmethyl]-L- lysine | C₄₁H₄₀N₂O₄ | TRC](https://www.trc-canada.com/prod-img/F640028.png)